Related Experiment Video
Updated: Jan 5, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
[The Role of microRNA in the Development of Ischemic Heart Disease]
N G Kukava1, R M Shkhnovich2, G Z Osmak3
1Institute of Clinical Cardiology named after A.L. Myasnikov, National Cardiology Research Center.
Abstract:
Coronary artery disease is the most clinically significant manifestation of atherosclerosis and the main cause of morbidity and mortality around the world. Atherogenesis is a complex process, involving various types of cells and regulatory molecules. MicroRNA molecules were discovered at the end of the 20th century, and nowadays are the important regulators of several pathophysiological processes of atherogenesis. The review examines data on the participation of various microRNAs in the development of atherosclerosis and its main clinical manifestations and discusses the possibility of using microRNAs as diagnostic markers for these diseases.
Insights
MicroRNAs regulate key processes in atherosclerosis development. This review explores their role in coronary artery disease and potential as diagnostic markers.
Area of Science:
- Biomedical Science
- Molecular Biology
- Cardiovascular Research
Background:
- Coronary artery disease (CAD) is a major global health burden, stemming from atherosclerosis.
- Atherogenesis is a complex biological process involving cellular and molecular interactions.
- MicroRNAs (miRNAs) have emerged as critical regulators in various pathophysiological pathways.
Purpose of the Study:
- To review the involvement of specific microRNAs in the development of atherosclerosis.
- To examine the role of microRNAs in the clinical manifestations of coronary artery disease.
- To discuss the potential of microRNAs as diagnostic biomarkers for atherosclerosis and CAD.
Main Methods:
- Literature review of scientific publications.
- Analysis of studies on microRNA function in atherogenesis.
- Synthesis of data on microRNA involvement in CAD.
Main Results:
- MicroRNAs are integral to the complex process of atherogenesis.
- Specific microRNAs are implicated in the progression of atherosclerosis.
- Evidence suggests microRNAs play a role in CAD's clinical outcomes.
Conclusions:
- MicroRNAs are significant regulators in the pathogenesis of atherosclerosis.
- MicroRNAs hold promise as potential diagnostic and prognostic biomarkers for CAD.
- Further research is warranted to translate miRNA findings into clinical applications.
More Related Videos
08:22Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
05:54Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart
Published on: February 3, 2023
Related Concept Videos
MicroRNAs
MicroRNAs
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology